Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BD's Vince Forlenza Highlights Sequestration Threat To MedTech Research

This article was originally published in The Gray Sheet

Executive Summary

At a Sept. 20 event in Washington, D.C., Becton Dickinson President and CEO Vince Forlenza said biomedical progress would be undermined by sequestration cuts to the National Institutes of Health. Meanwhile, a new poll shows many Americans oppose cutting medical research.


Related Content

Obama Points To ACA Payment Reforms As Cost Savers
People In Brief
Congress Set To Pass Six-Month Funding Bill, As Sequestration Still Looms





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts